- Home
- TSBK vs MNPR Comparison
TSBK vs MNPR Comparison
Compare TSBK & MNPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TSBK | MNPR |
|---|---|---|
| Founded | 1915 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 317.7M | 368.9M |
| IPO Year | 1997 | 2019 |
Fundamental Metrics
Financial Performance| Metric | TSBK | MNPR |
|---|---|---|
| Price | $41.66 | $60.60 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 11 |
| Target Price | N/A | ★ $107.00 |
| AVG Volume (30 Days) | 17.3K | ★ 163.9K |
| Earning Date | 04-28-2026 | 05-08-2026 |
| Dividend Yield | ★ 2.87% | N/A |
| EPS Growth | 21.93 | ★ 54.99 |
| EPS | ★ 1.94 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $21.33 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $29.96 | $29.18 |
| 52 Week High | $43.55 | $105.00 |
Technical Indicators
Market Signals| Indicator | TSBK | MNPR |
|---|---|---|
| Relative Strength Index (RSI) | 59.06 | 49.21 |
| Support Level | $37.50 | $51.32 |
| Resistance Level | $42.40 | $61.51 |
| Average True Range (ATR) | 0.97 | 4.40 |
| MACD | 0.14 | -0.54 |
| Stochastic Oscillator | 92.91 | 37.27 |
Price Performance
Historical ComparisonAbout TSBK Timberland Bancorp Inc.
Timberland Bancorp Inc is a bank holding company for Timberland Bank. The bank offers banking services including personal checking and savings accounts, debit cards, health savings accounts, online and mobile banking, online bill pay, 24-hour phone banking, and Zelle. Business services include business checking accounts, online banking, remote deposit, ACH transactions, Autobooks, and insured cash sweep services. The bank also provides lending services such as personal credit cards, home loans, home equity borrowing, construction loans, and SBA loans. In addition, it offers loans to real estate, including residential and commercial real estate, multi-family construction loans, one- to four-family residential loans, multi-family loans, commercial real estate loans, and land loans.
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.